C-peptide test can help in the correct diagnosis and treatment of diabetes. This simple and cheap test can differentiate between Type-1 and Type-2 diabetes, as well as other genetic forms of diabetes.

Some patients who have had type 1 diabetes for decades can still produce C-peptide and respond to hyperglycemia, suggesting residual β-cell function.

Although ‘lean type 2 diabetes’ is not uncommon, clinicians must first exclude other causes including autoimmune, monogenic, ...

Of those, 49 patients showed a C-peptide level greater than 200 pmol/L, of whom 38 were re-classified with type 2 diabetes, and 11 patients await re-classification and monogenic diabetes results.

Background: Connecting peptide (C-peptide) plays a role in early atherogenesis in patients with diabetes mellitus and may be a marker for cardiovascular morbidity and mortality in patients without ...

C-Peptide: A 31–amino acid peptide cleaved from proinsulin, co-secreted with insulin, and implicated in cellular signalling pathways that modulate inflammation, oxidative stress, and apoptosis.

Using a more convenient, cheaper C-peptide test a few years after diagnosis of type 1 diabetes can help pinpoint occasional patients who have been misdiagnosed. News & Perspective Drugs & Diseases ...

Though intensive diabetes management did not have a beneficial impact on C-peptide, Beck said, the study showed automated insulin delivery still has a beneficial effect for youths newly diagnosed ...

Once-daily oral verapamil may help preserve stimulated C-peptide secretion for children and adolescents with type 1 diabetes, according to a study published in JAMA. In findings from a randomized ...

This randomized, multicenter study of children and adolescents with new-onset type 1 diabetes (T1D) investigated the effect on glucose control of a closed-loop system, using C-peptide levels to ...

Strong Correlation between C-peptide and HbA1c: An analysis of the severe insulin-deficient diabetes subgroup of participants (n=23) who were uncontrolled on at least one prior antihyperglycemic ...